Nasal Drug Delivery

SNBL’s nasal drug delivery platform is a proprietary system consisting of powder carrier technology and delivery device technology.

Expertise in Nasal Delivery

3D Nasal Cast Model

preview
next

News Release: SNBL Nasal Delivery Technology in The 505(b)(2) Forum

Seminar The 505(b)(2) Forum (http://www.505b2forum.com/)
-THE 505(B)(2) PATHWAY: A CASE-BY-CASE REVIEW OF NEW TECHNOLOGIES AND DEVELOPMENT TECHNIQUES-
Title OBTAINING FDA ACCEPTANCE FOR TWO DIFFERENTIATED NASAL ABSORPTION DELIVERIES
WITHOUT PHASE III
Date Monday, October 27, 2014, 18:30 - 21:00
Site Bethesda North Marriott Hotel and Conference Center, North Bethesda, MD, USA

In conjunction with Camargo Pharmaceutical Services, leaders in the area of 505(b)(2) development programs, SNBL will present our experience of two programs using SNBL's μco™ System, which obtained the FDA's acceptance for approval without Phase 3 clinical efficacy studies. 

 

For more information, click here.

The 505(b)(2) Forum was organized by product developers and service providers interested in improving best practices across the 505(b)(2) development process. This forum will be held during the GPhA Fall Technical Conference.